|
|
Volumn 13, Issue 3, 1999, Pages 429-430
|
|
Why are the decay rates in plasma HIV-1 different for different treatments and in different patient populations? [7]
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CD4 ANTIGEN;
LAMIVUDINE;
NELFINAVIR;
NEVIRAPINE;
ZIDOVUDINE;
HALF LIFE TIME;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS 1;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
LETTER;
LYMPHOCYTE COUNT;
MATHEMATICAL MODEL;
PRIORITY JOURNAL;
VIRUS LOAD;
ANTI-HIV AGENTS;
CHILD, PRESCHOOL;
HALF-LIFE;
HIV INFECTIONS;
HIV-1;
HUMANS;
INFANT;
INFANT, NEWBORN;
RNA, VIRAL;
VIRAL LOAD;
|
|
EID: 0033008048
PISSN: 02699370
EISSN: None
Source Type: Journal
DOI: 10.1097/00002030-199902250-00022 Document Type: Letter |
|
Times cited : (10)
|
|
References (10)
|
